#China #Shanghai #CAR-T therapy #Medical Innovation #Jiahui Health

Jiahui International Cell Therapy Center Opens

On October 23, 2026, Jiahui International Hospital officially launched the Jiahui International Cell Therapy Center in Shanghai, a pivotal step in enhancing access to cutting-edge CAR-T therapies for patients both locally and globally. This new facility is a testament to Jiahui's commitment to medical innovation and its prowess in handling complex medical cases, especially in the field of cell therapy.

A Groundbreaking Summit

The center was unveiled during the inaugural Jiahui International Cell Therapy Summit, which attracted live stream participants from 14 different countries and regions. This event brought together leading experts in the field, including Prof. HAO Siguo and Prof. XUAN Linli, who engaged in discussions about the latest advancements in cellular therapies for various health conditions, including blood cancers and autoimmune diseases. The cross-national representation underscored the growing global interest in CAR-T treatments and Jiahui's role as a leader in this sector.

The Importance of CAR-T Therapy

CAR-T therapy, which stands for Chimeric Antigen Receptor T-cell therapy, has emerged as one of the most promising treatments for hematologic malignancies. It involves modifying a patient's T cells to better recognize and attack cancerous cells. Jiahui's International Cancer Center (JICC) has built a substantial reputation through its pioneering CAR-T cases, including successful treatments that have significantly improved patient outcomes. Notably, JICC made headlines when it treated China's first international patient with the axicabtagene ciloleucel (Axi-Cel) CAR-T therapy in September 2023. This patient, a woman from Singapore diagnosed with primary mediastinal large B-cell lymphoma, has remained relapse-free for over three years following her treatment. Such successful cases serve as a beacon of hope for many who face similar diagnoses.

Recognizing International Achievements

The summit was graced by Eric J. Rubin, Editor-in-Chief of the New England Journal of Medicine, who highlighted the increasing presence of Chinese research in global medical literature, emphasizing a shift from one publication a decade ago to over twenty in 2026. This change not only reflects the advancement of medical research in China but also Jiahui's commitment to contributing to this pool of knowledge.

Prof. John K. HSIANG, Chairman of Jiahui Health Executive Committee, reaffirmed the significance of such milestones in showcasing China's breakthroughs in medical innovation. Jiahui's achievements are not limited to CAR-T therapies. The center's efforts to link cutting-edge research with clinical applications have established it as a pivotal player in both local and international healthcare landscapes.

A Response to Global Needs

The decision to establish the Jiahui International Cell Therapy Center was largely driven by rising international demand for advanced medical services. Jiahui International Hospital receives nearly 500,000 patient visits annually from patients hailing from 180 countries. The new center aims to bridge the gap between cell therapy research and patient care, providing tailored services for international patients who seek these advanced treatments.

Future Prospects

The launch of the Jiahui International Cell Therapy Center marks a significant advancement in both healthcare and medical tourism in China, especially following the recent approval of Satri-cel (CT041), the world's first CAR-T therapy for solid tumors. Jiahui has been among the first institutions to clinically implement this therapy, treating its inaugural international recipient, a 59-year-old patient from New Zealand with advanced gastroduodenal cancer.

As the Jiahui International Cell Therapy Center opens its doors, it stands ready to cater to a growing number of patients from across the globe and continues to demonstrate Jiahui's unwavering commitment to enhancing global healthcare access, promoting innovation, and setting high standards in treatment practices.

For further information, please visit Jiahui Health's official website or contact the Jiahui International Cancer Center via email at [email protected] or through WhatsApp at +852 4619 1904.